207801-27-2
207801-27-2
Chemical Structure
Yohimbic acid hydrate
- CAS No.: 207801-27-2
- Formula:C20H26N2O4
- Molecular Weight:358.43
IUPAC Name: (1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid hydrate
InChIKey: UXXCUDYYOMDFPX-GPRFVYSASA-N
SMILES: [H][C@]12C3=C(CCN1C[C@]4([H])CC[C@@H]([C@@H]([C@@]4([H])C2)C(O)=O)O)C(C=CC=C5)=C5N3.O
Biological Activity: Yohimbic acid hydrate is a derivative of Yohimbine Hydrochloride (HY-N0127). Yohimbic acid hydrate exhibits vasodilatory and anticancer activities. Yohimbic acid hydrate can be used for the research of cancer, inflammation and cardiovascular disease[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Yohimbic acid hydrate | 99.96% | Yohimbic acid hydrate is a derivative of Yohimbine Hydrochloride (HY-N0127). Yohimbic acid hydrate exhibits vasodilatory and anticancer activities. Yohimbic acid hydrate can be used for the research of cancer, inflammation and cardiovascular disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Wang S, et, al. Significantly dysregulated genes in osteoarthritic labrum cells identified through gene expression profiling. Mol Med Rep. 2019 Aug; 20(2): 1716-1724. [Content Brief]
- [2]. Dai H, et al. Integrating single-cell multi-omics and machine learning to reveal triaptosis heterogeneity in clear cell renal cell carcinoma. Hum Genomics. Published online May 7, 2026. [Content Brief]
- [3]. RAYMOND HAMET. [Demonstration of the direct vasodilatory action of yohimbic acid and Py-tetrahydroquinoline]. C R Hebd Seances Acad Sci. 1960 Jun 27;250:4473-5. [Content Brief]
